Ignite Creation Date:
2025-12-24 @ 9:11 PM
Ignite Modification Date:
2025-12-25 @ 7:01 PM
Study NCT ID:
NCT00438204
Status:
TERMINATED
Last Update Posted:
2021-04-13
First Post:
2007-02-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Pemetrexed Disodium, Gemcitabine, and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-05
Start Date Type:
None
Primary Completion Date:
2013-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-20
First Submit QC Date:
None
Study First Post Date:
2007-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-04
Results First Submit QC Date:
None
Results First Post Date:
2014-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-23
Last Update Post Date:
2021-04-13
Last Update Post Date Type:
ACTUAL